MGTX
MeiraGTx Holdings plc
NASDAQ · Healthcare · Biotechnology · US
$13.76
−1.54%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 43.92x
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 50.41x
Trailing multiples
Trailing twelve months
- P/E TTM
- 18.10x
- PEG TTM
- —
- Price / book
- 6.13x
- Price / sales
- 3.32x
- Price / cash flow
- 96.51x
Enterprise value
- Enterprise value
- $1.3B
- EV / sales
- 3.25x
- EV / EBITDA
- 4.97x
- EV / EBIT
- 7.01x
- Market cap
- $1.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026